Loading…

Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction

ABSTRACT Objective To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction. Materials and Methods A total of 60 patients diagnosed with erectile dysfunction were retrospectiv...

Full description

Saved in:
Bibliographic Details
Published in:International Brazilian Journal of Urology 2017-03, Vol.43 (2), p.317-324
Main Authors: Karabakan, Mehmet, Keskin, Ercument, Akdemir, Serkan, Bozkurt, Aliseydi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593
cites cdi_FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593
container_end_page 324
container_issue 2
container_start_page 317
container_title International Brazilian Journal of Urology
container_volume 43
creator Karabakan, Mehmet
Keskin, Ercument
Akdemir, Serkan
Bozkurt, Aliseydi
description ABSTRACT Objective To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction. Materials and Methods A total of 60 patients diagnosed with erectile dysfunction were retrospectively evaluated using the international index of erectile function questionnaire-5 (IIEF-5), intravaginal ejaculatory latency time (IELT) and international prostate symptoms scores (IPSS). After the patients were treated with 5mg tadalafil once a day for three months, their erection, ejaculation and LUTS were assessed again. The fasting levels of blood glucose, total testosterone, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were measured. The independent-samples t-test was used to compare the pre- and post-treatment scores of the patients. Results The mean age of the 60 participants was 50.4±7.9 and the mean baseline serum total testosterone, total cholesterol, and fasting blood sugar were 444.6±178.6ng dL-1, 188.7±29.6mg/dL-1,104 (80-360) mg dL-1, respectively. The mean baseline scores were 2.2±1.4 min for IELT, 9.5±3.7 for IIEF-5 and 14.1±4.5 for IPSS. Following the three-month daily 5mg tadalafil treatment, the scores were found to be 3.4±1.9 min, 16.1±4.7, and 10.4±3.8 for IELT, IIEF and IPSS, respectively. When the baseline and post-treatment scores were compared, a statistically significant increase was observed in the IELTs and IIEF-5 values whereas there was a significant decrease in IPSS (p
doi_str_mv 10.1590/s1677-5538.ibju.2016.0376
format article
fullrecord <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5433372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_67c431d723b8447f894e4f2934370444</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5433372</sourcerecordid><originalsourceid>FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593</originalsourceid><addsrcrecordid>eNpVkdFuFCEUhidGY2v1HfDeXWGAYbgxMU3VJk280WtyBg67bGaGDTA2-yo-bZmuVntBODn_z3c4-ZvmPaNbJjX9mFmn1EZK3m_DcFi2LWXdlnLVvWgun6SX_9UXzZucD5S2mir2urloVc-0kv1l8_vGe7SFRE8KOBjBh5HIaUcchPFESkIoE87VMJOyR4IHsMsIJaYqhgnzBzLGe0xkSWGGtZmg4vJpOpY4ZQKzI5jqhDAi8ctci0oKMzlCCZWbyX0o-38Wd8p_XW-bVx7GjO_-3FfNzy83P66_be6-f729_ny3sbIXZaOZb-tBpThQ3iEOzCkYGNeSDTBwzWjrettqb5221jF0IBn1yLlirdT8qrk9c12EgzmmMNU9TIRgHhsx7QykEuyIplNW8Ipv-dALoXyvBYo6nguuqBCisj6dWcdlmNDZumGC8Rn0uTKHvdnFX0YKXv_TVoA-A2yKOSf0T28ZNWv45jF8s6Zq1vDNGr5Zw-cPH5in2w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction</title><source>PMC (PubMed Central)</source><source>SciELO</source><creator>Karabakan, Mehmet ; Keskin, Ercument ; Akdemir, Serkan ; Bozkurt, Aliseydi</creator><creatorcontrib>Karabakan, Mehmet ; Keskin, Ercument ; Akdemir, Serkan ; Bozkurt, Aliseydi</creatorcontrib><description>ABSTRACT Objective To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction. Materials and Methods A total of 60 patients diagnosed with erectile dysfunction were retrospectively evaluated using the international index of erectile function questionnaire-5 (IIEF-5), intravaginal ejaculatory latency time (IELT) and international prostate symptoms scores (IPSS). After the patients were treated with 5mg tadalafil once a day for three months, their erection, ejaculation and LUTS were assessed again. The fasting levels of blood glucose, total testosterone, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were measured. The independent-samples t-test was used to compare the pre- and post-treatment scores of the patients. Results The mean age of the 60 participants was 50.4±7.9 and the mean baseline serum total testosterone, total cholesterol, and fasting blood sugar were 444.6±178.6ng dL-1, 188.7±29.6mg/dL-1,104 (80-360) mg dL-1, respectively. The mean baseline scores were 2.2±1.4 min for IELT, 9.5±3.7 for IIEF-5 and 14.1±4.5 for IPSS. Following the three-month daily 5mg tadalafil treatment, the scores were found to be 3.4±1.9 min, 16.1±4.7, and 10.4±3.8 for IELT, IIEF and IPSS, respectively. When the baseline and post-treatment scores were compared, a statistically significant increase was observed in the IELTs and IIEF-5 values whereas there was a significant decrease in IPSS (p&lt;0.01). Conclusion A daily dose of 5mg tadalafil can be safely used in the treatment of erectile dysfunction and LUTS, that prolongs the ejaculatory latency time.</description><identifier>ISSN: 1677-5538</identifier><identifier>ISSN: 1677-6119</identifier><identifier>EISSN: 1677-5538</identifier><identifier>EISSN: 1677-6119</identifier><identifier>DOI: 10.1590/s1677-5538.ibju.2016.0376</identifier><identifier>PMID: 27819758</identifier><language>eng</language><publisher>Sociedade Brasileira de Urologia</publisher><subject>Ejaculation ; Erectile Dysfunction ; Original ; Tadalafil ; Therapeutics</subject><ispartof>International Brazilian Journal of Urology, 2017-03, Vol.43 (2), p.317-324</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593</citedby><cites>FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433372/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433372/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Karabakan, Mehmet</creatorcontrib><creatorcontrib>Keskin, Ercument</creatorcontrib><creatorcontrib>Akdemir, Serkan</creatorcontrib><creatorcontrib>Bozkurt, Aliseydi</creatorcontrib><title>Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction</title><title>International Brazilian Journal of Urology</title><description>ABSTRACT Objective To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction. Materials and Methods A total of 60 patients diagnosed with erectile dysfunction were retrospectively evaluated using the international index of erectile function questionnaire-5 (IIEF-5), intravaginal ejaculatory latency time (IELT) and international prostate symptoms scores (IPSS). After the patients were treated with 5mg tadalafil once a day for three months, their erection, ejaculation and LUTS were assessed again. The fasting levels of blood glucose, total testosterone, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were measured. The independent-samples t-test was used to compare the pre- and post-treatment scores of the patients. Results The mean age of the 60 participants was 50.4±7.9 and the mean baseline serum total testosterone, total cholesterol, and fasting blood sugar were 444.6±178.6ng dL-1, 188.7±29.6mg/dL-1,104 (80-360) mg dL-1, respectively. The mean baseline scores were 2.2±1.4 min for IELT, 9.5±3.7 for IIEF-5 and 14.1±4.5 for IPSS. Following the three-month daily 5mg tadalafil treatment, the scores were found to be 3.4±1.9 min, 16.1±4.7, and 10.4±3.8 for IELT, IIEF and IPSS, respectively. When the baseline and post-treatment scores were compared, a statistically significant increase was observed in the IELTs and IIEF-5 values whereas there was a significant decrease in IPSS (p&lt;0.01). Conclusion A daily dose of 5mg tadalafil can be safely used in the treatment of erectile dysfunction and LUTS, that prolongs the ejaculatory latency time.</description><subject>Ejaculation</subject><subject>Erectile Dysfunction</subject><subject>Original</subject><subject>Tadalafil</subject><subject>Therapeutics</subject><issn>1677-5538</issn><issn>1677-6119</issn><issn>1677-5538</issn><issn>1677-6119</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkdFuFCEUhidGY2v1HfDeXWGAYbgxMU3VJk280WtyBg67bGaGDTA2-yo-bZmuVntBODn_z3c4-ZvmPaNbJjX9mFmn1EZK3m_DcFi2LWXdlnLVvWgun6SX_9UXzZucD5S2mir2urloVc-0kv1l8_vGe7SFRE8KOBjBh5HIaUcchPFESkIoE87VMJOyR4IHsMsIJaYqhgnzBzLGe0xkSWGGtZmg4vJpOpY4ZQKzI5jqhDAi8ctci0oKMzlCCZWbyX0o-38Wd8p_XW-bVx7GjO_-3FfNzy83P66_be6-f729_ny3sbIXZaOZb-tBpThQ3iEOzCkYGNeSDTBwzWjrettqb5221jF0IBn1yLlirdT8qrk9c12EgzmmMNU9TIRgHhsx7QykEuyIplNW8Ipv-dALoXyvBYo6nguuqBCisj6dWcdlmNDZumGC8Rn0uTKHvdnFX0YKXv_TVoA-A2yKOSf0T28ZNWv45jF8s6Zq1vDNGr5Zw-cPH5in2w</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Karabakan, Mehmet</creator><creator>Keskin, Ercument</creator><creator>Akdemir, Serkan</creator><creator>Bozkurt, Aliseydi</creator><general>Sociedade Brasileira de Urologia</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170301</creationdate><title>Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction</title><author>Karabakan, Mehmet ; Keskin, Ercument ; Akdemir, Serkan ; Bozkurt, Aliseydi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Ejaculation</topic><topic>Erectile Dysfunction</topic><topic>Original</topic><topic>Tadalafil</topic><topic>Therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karabakan, Mehmet</creatorcontrib><creatorcontrib>Keskin, Ercument</creatorcontrib><creatorcontrib>Akdemir, Serkan</creatorcontrib><creatorcontrib>Bozkurt, Aliseydi</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International Brazilian Journal of Urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karabakan, Mehmet</au><au>Keskin, Ercument</au><au>Akdemir, Serkan</au><au>Bozkurt, Aliseydi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction</atitle><jtitle>International Brazilian Journal of Urology</jtitle><date>2017-03-01</date><risdate>2017</risdate><volume>43</volume><issue>2</issue><spage>317</spage><epage>324</epage><pages>317-324</pages><issn>1677-5538</issn><issn>1677-6119</issn><eissn>1677-5538</eissn><eissn>1677-6119</eissn><abstract>ABSTRACT Objective To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction. Materials and Methods A total of 60 patients diagnosed with erectile dysfunction were retrospectively evaluated using the international index of erectile function questionnaire-5 (IIEF-5), intravaginal ejaculatory latency time (IELT) and international prostate symptoms scores (IPSS). After the patients were treated with 5mg tadalafil once a day for three months, their erection, ejaculation and LUTS were assessed again. The fasting levels of blood glucose, total testosterone, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were measured. The independent-samples t-test was used to compare the pre- and post-treatment scores of the patients. Results The mean age of the 60 participants was 50.4±7.9 and the mean baseline serum total testosterone, total cholesterol, and fasting blood sugar were 444.6±178.6ng dL-1, 188.7±29.6mg/dL-1,104 (80-360) mg dL-1, respectively. The mean baseline scores were 2.2±1.4 min for IELT, 9.5±3.7 for IIEF-5 and 14.1±4.5 for IPSS. Following the three-month daily 5mg tadalafil treatment, the scores were found to be 3.4±1.9 min, 16.1±4.7, and 10.4±3.8 for IELT, IIEF and IPSS, respectively. When the baseline and post-treatment scores were compared, a statistically significant increase was observed in the IELTs and IIEF-5 values whereas there was a significant decrease in IPSS (p&lt;0.01). Conclusion A daily dose of 5mg tadalafil can be safely used in the treatment of erectile dysfunction and LUTS, that prolongs the ejaculatory latency time.</abstract><pub>Sociedade Brasileira de Urologia</pub><pmid>27819758</pmid><doi>10.1590/s1677-5538.ibju.2016.0376</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1677-5538
ispartof International Brazilian Journal of Urology, 2017-03, Vol.43 (2), p.317-324
issn 1677-5538
1677-6119
1677-5538
1677-6119
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5433372
source PMC (PubMed Central); SciELO
subjects Ejaculation
Erectile Dysfunction
Original
Tadalafil
Therapeutics
title Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A13%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20tadalafil%205mg%20daily%20treatment%20on%20the%20ejaculatory%20times,%20lower%20urinary%20tract%20symptoms%20and%20erectile%20function%20in%20patients%20with%20erectile%20dysfunction&rft.jtitle=International%20Brazilian%20Journal%20of%20Urology&rft.au=Karabakan,%20Mehmet&rft.date=2017-03-01&rft.volume=43&rft.issue=2&rft.spage=317&rft.epage=324&rft.pages=317-324&rft.issn=1677-5538&rft.eissn=1677-5538&rft_id=info:doi/10.1590/s1677-5538.ibju.2016.0376&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5433372%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c584t-91f291fe773a036eeb1d7ab13951bab39102d8c29fcd9ccd1eda510fe33712593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27819758&rfr_iscdi=true